1. Zhu, Wenjing, Song, Shu, Xu, Yangchun, Sheng, Hanyue, Wang, Shuang. . EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy. In Cancer biomarkers : section A of Disease markers, 40, 227-239. doi:10.3233/CBM-230504. https://pubmed.ncbi.nlm.nih.gov/39213053/
2. Fumoto, Shoichi, Hiyama, Keiko, Tanimoto, Keiji, Noguchi, Tsuyoshi, Nishiyama, Masahiko. 2008. EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma. In Cancer letters, 274, 25-32. doi:10.1016/j.canlet.2008.08.021. https://pubmed.ncbi.nlm.nih.gov/18823699/
3. Alaminos, Miguel, Dávalos, Verónica, Ropero, Santiago, Gerald, William L, Esteller, Manel. . EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. In Cancer research, 65, 2565-71. doi:. https://pubmed.ncbi.nlm.nih.gov/15805250/
4. Li, Li, Xia, Siyu, Zhao, Zitong, Huang, Dayong, Xin, Tao. 2024. EMP3 as a prognostic biomarker correlates with EMT in GBM. In BMC cancer, 24, 89. doi:10.1186/s12885-023-11796-0. https://pubmed.ncbi.nlm.nih.gov/38229014/
5. Ma, Qiang, Zhang, Yijian, Liang, Haibin, Li, Maolan, Liu, Yingbin. 2023. EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression. In Cancer letters, 575, 216398. doi:10.1016/j.canlet.2023.216398. https://pubmed.ncbi.nlm.nih.gov/37730106/
6. Passarelli, Maria C, Pinzaru, Alexandra M, Asgharian, Hosseinali, Goodarzi, Hani, Tavazoie, Sohail F. 2022. Leucyl-tRNA synthetase is a tumour suppressor in breast cancer and regulates codon-dependent translation dynamics. In Nature cell biology, 24, 307-315. doi:10.1038/s41556-022-00856-5. https://pubmed.ncbi.nlm.nih.gov/35288656/
智鼠故事 
